Supernus Pharmaceuticals (SUPN) Price to Earnings (2012 - 2025)
Supernus Pharmaceuticals' (SUPN) Price to Earnings stood at 27.43 in Q2 2025, down 90.2% from 281.06 a year earlier and down 7.4% from the prior quarter.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Price to Earnings (2012 - 2025) Analysis & Trends
For FY2024, Supernus Pharmaceuticals' Price to Earnings came in at 27.29, down 97.7% from FY2023.
- Across earlier years, Price to Earnings came in at 1203.41 in FY2023, 31.88 in FY2022 (+9.7%), 29.07 in FY2021 (+177.4%) and 10.48 in FY2020 (-4.9%).
- Quarterly Price to Earnings has ranged from 8.49 in Q3 2020 to 1203.41 in Q4 2023 over the past five years.
- On a year-over-year basis, Price to Earnings rose in two of the last five quarters, with growth averaging 86.1%.
- Peak year-over-year performance for Price to Earnings in the last five years was growth of 647.0% in Q2 2024, against a decline of 97.7% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 29.62 (Q1 2025), 27.29 (Q4 2024) and 28.83 (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Supernus Pharmaceuticals | 2.47 Bn | 1.12 Bn | 185.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 27.43 |
| Mar 31, 2025 | 29.62 |
| Dec 31, 2024 | 27.29 |
| Sep 30, 2024 | 28.83 |
| Jun 30, 2024 | 281.06 |
| Dec 31, 2023 | 1,203.41 |
| Sep 30, 2023 | 58.38 |
| Jun 30, 2023 | 37.62 |
| Mar 31, 2023 | 37.77 |
| Dec 31, 2022 | 31.88 |
| Sep 30, 2022 | 47.85 |
| Jun 30, 2022 | 26.79 |
| Mar 31, 2022 | 23.47 |
| Dec 31, 2021 | 29.07 |
| Sep 30, 2021 | 17.25 |
| Jun 30, 2021 | 16.25 |
| Mar 31, 2021 | 12.46 |
| Dec 31, 2020 | 10.48 |
| Sep 30, 2020 | 8.49 |
| Jun 30, 2020 | 10.58 |
API Access
Supernus Pharmaceuticals Price to Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-earnings&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-earnings", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-earnings&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();